It is becoming clear that an adequate level of long-chain highly unsaturated fatty acids in the nervous system is required for optimal function and development; however, the ability of infants to biosynthesize long-chain fatty acids is unknown. This study explores the capacity of human infants to convert 18-carbon essential fatty acids to their elongated and desaturated forms, in vivo. A newly developed gas chromatography͞negative chemical ionization͞mass spectrometry method employing 2 H-labeled essential fatty acids allowed assessment of this in vivo conversion with very high sensitivity and selectivity. Our results demonstrate that human infants have the capacity to convert dietary essential fatty acids administered enterally as 2 H-labeled ethyl esters to their longer-chain derivatives, transport them to plasma, and incorporate them into membrane lipids. The in vivo conversion of linoleic acid (18:2n6) to arachidonic acid (20:4n6) is demonstrated in human beings. All elongases͞desaturases necessary for the conversion of linolenic acid (18:3n3) to docosahexaenoic acid (22:6n3) are also active in the first week after birth. Although the absolute amounts of n-3 fatty acid metabolites accumulated in plasma are greater than those of the n-6 family, estimates of the endogenous pools of 18:2n6 and 18:3n3 indicate that n-6 fatty acid conversion rates are greater than those of the n-3 family. While these data clearly demonstrate the capability of infants to biosynthesize 22:6n3, a lipid that is required for optimal neural development, the amounts produced in vivo from 18:3n3 may be inadequate to support the 22:6n3 level observed in breast-fed infants.
Polyunsaturated acids of the n-6 series are essential for proper growth and development (1) . This may be supplied as linoleic acid (18:2n6) , although arachidonic acid (20:4n6) may also be required (2) . Recent evidence derived from non-human primates suggests that n-3 fatty acids are also essential for optimal neural development (3) . In human infants, decreases in the level of plasma and erythrocyte membrane docosahexaenoate (22:6n3) are associated with poorer retinal development (4) and lower visual acuity as measured behaviorally by forced choice preferential looking testing and electrophysiologically using pattern reversal visual evoked potential methodology (5) . Cognitive scores at 12 months are also lower in infants fed docosahexaenoate-deficient formula (6) . This neural n-3 deficiency syndrome has been the subject of several recent reviews (7) (8) (9) (10) . Carlson et al. (11) have suggested that adequate 20:4n6 is also necessary for optimal growth and cognition. Birch et al. (5) found that a diet high in the n-3 precursor linolenate (18:3n3) was not able to support optimal visual function and that the supply of preformed 22:6n3 appeared necessary in premature infants (5) .
These studies underline the importance of understanding the metabolism of the 18-carbon essential fatty acids to their elongated and desaturated forms in vivo, particularly of 20:4n6 and 22:6n3. However, not only is there a complete lack of information concerning essential fatty acid metabolism in early human development but there is also a paucity of information in adults and in other primates. In vitro experiments have included the demonstration of ⌬6 desaturation of 14 C-labeled 18:2n6 or 18:3n3 and the ⌬5 desaturation of 20:3n6 in liver microsomes from human infants (12) as well as ⌬6 and ⌬5 desaturation of 18:3n3 and 20:3n6 in human lymphocytes (13) . Several in vivo experiments concerning fatty acid elongation͞desaturation have been attempted. In 1967, Nichaman et al. (14) gave an oral dose of 14 C-labeled 18:2n6 to four adult males and found the plasma radioactivity mainly in the form of esterified 18:2n6 but reported traces of radioactive 20:3n6 and 20:4n6 in plasma phospholipids. Emken and coworkers (15, 16) have orally administered stable isotope-labeled 18:2n6 and 18:3n3 and clearly demonstrated formation of deuterated plasma 22:6n3 in vivo in adult humans. However, no conversion of 18:2n6 to 20:4n6 was observed in these two studies. El Boustani et al. (17) have observed the conversion of deuterated 20:3n6 to 20:4n6 in vivo in four adults.
In this study, the ability of human infants to elongate and desaturate essential fatty acids in vivo has been examined using a highly sensitive and selective gas chromatography͞mass spectrometry method (18) for the detection of stable isotopelabeled metabolites released into plasma subsequent to an oral dose of deuterated fatty acids. Evidence for the enzymatic capacity for the in vivo production of 20:4n6 and 22:6n3 in newborn infants is presented. Infants in this study remained hospitalized after birth due to mild to moderately severe respiratory illness and͞or were being observed for possible complications resulting from neonatal asphyxia (Table 1) . Routine neonatal care and treatment were provided by a neonatologist from the Hospital Sotero del Rio in Santiago, Chile. Entry criteria included not being enterally fed at time of study and anticipated tolerance to enteral feedings, not being expected to require parenteral lipids during the course of the study, good glucose tolerance, absence of metabolic acidosis, and normal liver enzyme levels. Medications used in the customary care of infants recovering from asphyxia such as antibiotics or phenobarbital or an increase in ambient oxygen were not reasons to exclude infants from the study. In addition, the clinical caretaker and the parents agreed to include the infant in the study. Subjects were given 0.5 ml of a neat solution containing 50 or 100 mg of D 5 -labeled 18:2n6 and͞or D 5 -labeled 18:3n3 per kg of birth weight via a nasogastric tube over a 1-min period; 5 ml of sterile water was used to rinse the tube, which was then occluded to prevent loss of the label.
MATERIALS AND METHODS

Materials
The nine infants admitted to the study had birth weights ranging from 1980 to 3970 g and gestational ages of 32-41 weeks. Feedings were uncontrolled and consisted principally of human milk but also of commercial formulas; feeds were generally started at least 24 hr (range, 8-96 hr; Table 1 ) after isotope administration based on the decision of the physician providing clinical care. D 5 -fatty acid administration was performed on day 1-6 after birth. Then, at various times, Ϸ0.5 ml of blood was drawn from an antecubital vein into plastic tubes containing EDTA as anticoagulant; a maximal amount of 3.0 ml was drawn in total. The blood was separated immediately into packed red blood cells and plasma by centrifugation at 3000 rpm for 10 min in a clinical centrifuge. The plasma was pipetted into a separate tube and frozen at Ϫ80°C until analysis.
Fatty Acid Extraction and Derivatization. Internal standard (0.05 g of 23:0 methyl ester) was added to 0.20-ml plasma aliquots, and the lipids were extracted and the pentafluorobenzyl esters were analyzed by GC͞MS in the negative chemical ionization (NCI) mode using methods previously described (18, 19) .
RESULTS
When the ethyl ester forms of 2 H 5 -18:2n6 and 2 H 5 -18:3n3 were given by gavage to infants, they were rapidly absorbed and detected in plasma lipids. The dosage and type of each 2 H-labeled fatty acid given as well as information about the feeding of each infant is given in Table 1 . In all cases, the 2 H 5 -18:2n6 levels peaked in the 1-4 g͞ml plasma range within the first 24 hr (Fig. 1 A) . The plasma levels of 2 H 5 -18:3n3 were more variable and three of the seven infants exhibited a rather low accretion of this n-3 precursor (Fig. 1B) . The precise time of the maxima for essential fatty acid absorption was not determined, as the primary purpose of this work was to detect longer-chain metabolites that have maximas at later time points; the need to minimize blood draws for subject protection precluded obtaining additional time point data. However, it appeared that the 18:3n3 absorption peak was faster than that of 18:2n6 in these infants.
Since our GC͞MS method is capable of separation of the 2 H 5 -labeled fatty acids from their endogenous counterparts in time and by mass, the in vivo formation of long-chain polyunsaturates from 18-carbon precursors can be readily observed by inspection of the appropriate selected ion chromatograms (Fig. 2) . It is clear from The concentrations of plasma fatty acids were determined at the beginning and end of the experiment for each infant, during which time enteral feedings were initiated. The mean plasma concentrations of 18:2n6 at the beginning and end of the experiment were 95 and 372 g͞ml; those for 18:3n3 were The initial and final plasma n-6͞n-3 ratios were 3.8 and 9.6, respectively.
DISCUSSION
These data unambiguously demonstrate the conversion of 18:2n6 to 20:4n6 and 18:3n3 to 22:6n3 in human infants; this study is also the largest human study yet reported. Many investigators have attempted to study the in vivo conversion of 18-carbon essential fatty acids based upon alterations in fatty acid composition when various dietary changes are made. However, compositional studies cannot be interpreted in this manner due to possible exchanges of fatty acids between organs (20) . In this study, the precursor fatty acids were isotopically labeled with 2 H atoms and they, as well as their metabolites, were thus distinguishable from the corresponding endogenous molecules when highly specific mass spectrometric detection was used (18) . It is thus certain that elongation and desaturation of 18:2n6 and 18:3n3 occurred in vivo in these infants.
This study reports direct evidence of 20:4n6 formation from 18:2n6 in vivo in humans (Figs. 2 A and 3A) . Support for this finding is gained from previous findings that human fetal (21) or adult (22) liver microsomes are capable of 18:2n6 conversion to 20:4n6. Also, 20:3n6 may be converted to 20:4n6 in liver microsomes from human infants (12) and in vivo in adults (17 (15) . This apparent contradiction is attributed to the increased detectability achieved in the present study due to three factors: (i) increased sensitivity and selectivity due to complete gas chromatographic separation of the deuterated fatty acid from the endogenous peak due to the presence of five 2 H atoms on the methyl end of the molecule, (ii) the increase in sensitivity of several orders of magnitude and increased signal-to-noise ratio gained when using negative ion detection of the pentafluorobenzyl derivatives (18) , and (iii) blood sampling at time points greater than 48 hr, which, as shown in this study, is necessary in order to detect the maximal level of 2 H 5 -20:4n6 in plasma. The introduction of a period of fasting just prior to the isotope feeding may also be an important factor. In more recent work, Emken et al. (23) have presented data for the total n-6 metabolite production from deuterated-18:2n6 but have not shown any direct evidence for 20:4n6 production in vivo.
Although the plasma levels of 2 H 5 -20:4n6 were generally Ͻ100 ng͞ml (Fig. 3A) , it is not correct to interpret this as a very low rate of 18:2n6 conversion. Conversely, although the amounts of total long-chain n-3 metabolites reached 540 ng͞ml, it does not follow that the rate of 18:3n3 conversion is much greater than that of the n-6 family. The plasma specific activity is affected by the degree of absorption, elongation͞ desaturation, oxidation and other degradative processes, transport and removal from the plasma compartment to organs, and transacylation. The isotopically labeled fatty acids will be diluted into the endogenous pools in the liver and plasma and be representative of these pools based on the amount of this dilution. The differences in pool size between the endogenous 18:2n6 and 18:3n3 must therefore be taken into account. The mean plasma concentrations of 18:2n6 and 18:3n3 in these infants were 372 g͞ml and 3.2 g͞ml (at the end of the experiment), respectively, and assuming a similar volume of distribution thus represents a 116-fold difference in estimated pool size. Indeed, when this factor is considered, a more reasonable conclusion is that the rate of n-6 conversion is greater than that of the n-3 family.
An estimation of the total amount of long-chain polyunsaturated fatty acid metabolite formed may be made as follows: (i) the total amount of plasma deuterated precursor (i.e., 18:2n6 or 18:3n3) is estimated by integrating its time course plot, (ii) the total amount of endogenous plasma precursor fatty acid is estimated from integrating a two-point plot of its time course, (iii) the isotope dilution factor in the plasma may be computed from the ratio of the above, (iv) the total amount of deuterated long-chain polyunsaturated fatty acid plasma metabolites may be estimated from the integration of their time course plots, (v) multiplication of the precursor isotope dilution factor by the total amount of deuterated metabolite then yields a minimal value for the total amount of metabolite produced in the time period of the experiment. If this method of estimation is used for subject 3 (s3), the quantities produced over the 6-day period of the experiment for 20:3n6, 20:4n6, 20:5n3, 22:5n3, and 22:6n3 are approximately 110, 53, 1.3, 0.3, and 0.9 mg. This example illustrates the powerful effect on the conclusions drawn when the differences in the endogenous pools of 18:2n6 and 18:3n3 are considered. The limitations of this estimate must also be explicitly recognized. It assumes that the isotope is homogeneously diluted into the plasma pool and that this dilution is maintained in the liver where enzymatic conversion occurs. The amounts calculated are minimums as only the plasma pool is measured and organ pools are not taken into account. Also, the amounts of the precursors are underestimated due to limited blood sampling points during their rising phase within the first 24 hr. Finally, it must be noted that these infants were all hospitalized for treatment of various ailments (Table 1) Our observations indicate that infants as small as 2 kg (and 32 weeks gestational age) are capable of elongation and desaturation of essential fatty acids and, in particular, are capable of forming plasma 20:4n6 and 22:6n3. These findings have implications for the question of their dietary fat requirements. Recent autopsy studies by Makrides et al. (25) and by Farquharson et al. (26) of infants fed infant formula or mother's milk have shown a decrease in brain 22:6n3 in those fed formulas devoid of 22:6n3 but containing 18:3n3. A large body of studies now exists which suggests that the decrease in brain 22:6n3 associated with vegetable oil-based formulas leads to suboptimal neural development and performance (3) (4) (5) (6) (7) (8) (9) (10) (11) (27) (28) (29) (30) (31) (32) (33) . Apparently the rate of 22:6n3 formation from 18:3n3 is inadequate at this early stage of life. Additional studies are needed to define the optimal manner in which long-chain polyunsaturated fatty acid requirements of artificially fed human infants may be met.
